EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaPublications in collaboration with researchers from Hospital de Gran Canaria Dr. Negrin (2)
2013
-
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
British Journal of Cancer, Vol. 109, Núm. 1, pp. 121-130
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572